| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |